Mandate

Vinge advises when Lendify, a fintech company and one of Sweden’s largest challengers to the banking sector, completes a share issue of SEK 148m

April 22, 2020 M&A

Vinge has advised Lendify AB (publ) (”Lendify”) in connection with raising of capital from new and current shareholders in an investment round in a total amount of approximately SEK 148 million.

The issue occurs at a valuation of Lendify of approximately SEK 1.5 billion (prior to the investment).

Vinge’s team primarily consisted of partner Jonas Johansson together with associates Filip Öhrner, Anna Thoms and Hanna Risberg.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025